Documents
Application Sponsors
Marketing Status
Discontinued | 001 |
Prescription | 002 |
Application Products
001 | TABLET;ORAL-21 | 0.03MG;0.3MG | 0 | LOW-OGESTREL-21 | ETHINYL ESTRADIOL; NORGESTREL |
002 | TABLET;ORAL-28 | 0.03MG;0.3MG | 0 | LOW-OGESTREL-28 | ETHINYL ESTRADIOL; NORGESTREL |
FDA Submissions
| ORIG | 1 | AP | 1999-07-28 | |
LABELING; Labeling | SUPPL | 8 | AP | 2005-06-24 | |
LABELING; Labeling | SUPPL | 21 | AP | 2017-08-09 | STANDARD |
LABELING; Labeling | SUPPL | 23 | AP | 2022-02-28 | STANDARD |
LABELING; Labeling | SUPPL | 24 | AP | 2022-04-29 | STANDARD |
Submissions Property Types
SUPPL | 21 | Null | 15 |
SUPPL | 23 | Null | 15 |
SUPPL | 24 | Null | 15 |
TE Codes
CDER Filings
MAYNE PHARMA
cder:Array
(
[0] => Array
(
[ApplNo] => 75288
[companyName] => MAYNE PHARMA
[docInserts] => ["",""]
[products] => [{"drugName":"LOW-OGESTREL-21","activeIngredients":"ETHINYL ESTRADIOL; NORGESTREL","strength":"0.03MG;0.3MG","dosageForm":"TABLET;ORAL-21","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"},{"drugName":"LOW-OGESTREL-28","activeIngredients":"ETHINYL ESTRADIOL; NORGESTREL","strength":"0.03MG;0.3MG","dosageForm":"TABLET;ORAL-28","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
[labels] => [{"actionDate":"07\/28\/1999","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/anda\\\/99\\\/75288_Norgestrel%20And%20Ethinyl%20Estradiol_Prntlbl.pdf\"}]","notes":""}]
[originalApprovals] => [{"actionDate":"LOW-OGESTREL-21","submission":"ETHINYL ESTRADIOL; NORGESTREL","actionType":"0.03MG;0.3MG","submissionClassification":"TABLET;ORAL-21","reviewPriority":"Discontinued","inserts":"[]","notes":">No"},{"actionDate":"LOW-OGESTREL-28","submission":"ETHINYL ESTRADIOL; NORGESTREL","actionType":"0.03MG;0.3MG","submissionClassification":"TABLET;ORAL-28","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1999-07-28
)
)